Back to top
Merck & Co. (MRK)
(Delayed Data from NYSE)
$96.63 USD
96.63
11,512,980
+0.95 (0.99%)
Updated Jan 23, 2025 04:00 PM ET
After-Market: $96.61 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
View All Zacks #1 Ranked StocksCash flow Statements
Fiscal Year End for Merck & Co, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Cash Flow From Operations, Investments & Financial Activities |
|||||
| Net Income (Loss) | NA | 377.00 | 14,526.00 | 12,358.00 | 7,082.00 |
| Depreciation/Amortization & Depletion | NA | 3,872.00 | 3,909.00 | 3,214.00 | 3,625.00 |
| Net Change from Assets/Liabilities | NA | -2,205.00 | -2,782.00 | -3,839.00 | -4,590.00 |
| Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Activities | NA | 10,962.00 | 3,442.00 | 1,389.00 | 4,136.00 |
| Net Cash From Operating Activities | NA | 13,006.00 | 19,095.00 | 13,122.00 | 10,253.00 |
| Property & Equipment | NA | -3,863.00 | -4,388.00 | -4,448.00 | -4,684.00 |
| Acquisition/ Disposition of Subsidiaries | NA | -12,032.00 | -121.00 | -12,907.00 | -6,606.00 |
| Investments | NA | 1,848.00 | -483.00 | 1,025.00 | 2,717.00 |
| Other Investing Activities | NA | -36.00 | 32.00 | -91.00 | -870.00 |
| Net Cash from Investing Activities | NA | -14,083.00 | -4,960.00 | -16,421.00 | -9,443.00 |
Uses of Funds
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Issuance (Repurchase) of Capital Stock | NA | -1,221.00 | 384.00 | -638.00 | -1,192.00 |
| Issuance (Repayment) of Debt | NA | 4,184.00 | -2,251.00 | 5,617.00 | 2,462.00 |
| Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | -3,986.00 | 2,549.00 |
| Payment of Dividends & Other Distributions | NA | -7,445.00 | -7,012.00 | -6,610.00 | -6,215.00 |
| Other Financing Activities | NA | -328.00 | -240.00 | 8,714.00 | -436.00 |
| Net Cash from Financing Activities | NA | -4,810.00 | -9,119.00 | 3,097.00 | -2,832.00 |
| Effect of Exchange Rate Changes | NA | 23.00 | -410.00 | 216.00 | 253.00 |
| Net Change In Cash & Equivalents | NA | -5,864.00 | 4,606.00 | 14.00 | -1,769.00 |
| Cash at Beginning of Period | NA | 12,773.00 | 8,167.00 | 8,153.00 | 9,934.00 |
| Cash at End of Period | NA | 6,909.00 | 12,773.00 | 8,167.00 | 8,165.00 |
| Diluted Net EPS | NA | 0.14 | 5.71 | 5.14 | 2.78 |
Fiscal Year End for Merck & Co, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
| 12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Cash Flow From Operations, Investments & Financial Activities |
|||||
| Net Income (Loss) | NA | 13,389.00 | 10,228.00 | 4,767.00 | 377.00 |
| Depreciation/Amortization & Depletion | NA | 3,302.00 | 2,116.00 | 984.00 | 3,872.00 |
| Net Change from Assets/Liabilities | NA | -1,812.00 | -4,394.00 | -3,382.00 | -2,205.00 |
| Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Activities | NA | 3,139.00 | 777.00 | 721.00 | 10,962.00 |
| Net Cash From Operating Activities | NA | 18,018.00 | 8,727.00 | 3,090.00 | 13,006.00 |
| Property & Equipment | NA | -2,435.00 | -1,652.00 | -861.00 | -3,863.00 |
| Acquisition/ Disposition of Subsidiaries | NA | -4,091.00 | -746.00 | -746.00 | -12,032.00 |
| Investments | NA | 306.00 | 256.00 | 245.00 | 1,848.00 |
| Other Investing Activities | NA | -70.00 | -303.00 | -14.00 | -36.00 |
| Net Cash from Investing Activities | NA | -6,290.00 | -2,445.00 | -1,376.00 | -14,083.00 |
Uses of Funds
| 12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Issuance (Repurchase) of Capital Stock | NA | -652.00 | -213.00 | -35.00 | -1,221.00 |
| Issuance (Repayment) of Debt | NA | 2,848.00 | 2,849.00 | -751.00 | 4,184.00 |
| Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Dividends & Other Distributions | NA | -5,889.00 | -3,936.00 | -1,950.00 | -7,445.00 |
| Other Financing Activities | NA | -330.00 | -298.00 | -78.00 | -328.00 |
| Net Cash from Financing Activities | NA | -4,023.00 | -1,598.00 | -2,814.00 | -4,810.00 |
| Effect of Exchange Rate Changes | NA | 74.00 | -220.00 | -138.00 | 23.00 |
| Net Change In Cash & Equivalents | NA | 7,779.00 | 4,464.00 | -1,238.00 | -5,864.00 |
| Cash at Beginning of Period | NA | 6,909.00 | 6,909.00 | 6,909.00 | 12,773.00 |
| Cash at End of Period | NA | 14,688.00 | 11,373.00 | 5,671.00 | 6,909.00 |
| Diluted Net EPS | NA | 1.24 | 2.14 | 1.87 | -0.48 |